US Stock MarketDetailed Quotes

ENFN Enfusion

Watchlist
  • 10.130
  • -0.010-0.10%
Close Dec 3 16:00 ET
  • 10.130
  • 0.0000.00%
Post 16:20 ET
955.99MMarket Cap253.25P/E (TTM)

Enfusion Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
33.50%16.16M
21.54%7.31M
65.91%1.53M
81.08%25.63M
-12.43%6.59M
54.37%12.11M
108.24%6.02M
122.55%924K
4,551.57%14.16M
229.40%7.52M
Net income from continuing operations
-26.46%1.96M
155.21%2.55M
-116.21%-761K
169.77%9.25M
14.21%900K
2.42%2.66M
124.19%998K
137.48%4.69M
95.30%-13.26M
100.27%788K
Operating gains losses
----
----
----
--78K
--0
----
----
----
----
----
Depreciation and amortization
17.37%2.96M
37.99%2.87M
43.15%2.67M
57.42%9.99M
107.99%3.52M
48.44%2.52M
28.92%2.08M
39.40%1.87M
59.60%6.34M
28.42%1.69M
Other non cash items
-9.22%1.81M
22.02%2.1M
17.53%1.82M
29.70%6.97M
11.40%1.71M
55.98%2M
-32.85%1.72M
25,766.67%1.55M
2,322.07%5.38M
--1.54M
Change In working capital
266.49%5.59M
-200.13%-4.71M
-39.06%-9.06M
11.77%-9.44M
-243.95%-2.87M
48.64%1.53M
69.58%-1.57M
-13.87%-6.52M
27.45%-10.69M
84.61%-835K
-Change in receivables
575.38%1.85M
-207.60%-3.16M
-410.02%-2.72M
59.26%-3.68M
-204.73%-3.14M
61.88%-390K
81.99%-1.03M
116.53%878K
-20.53%-9.03M
857.32%3M
-Change in prepaid assets
2.14%907K
49.61%947K
-181.98%-414K
1.02%-1.75M
5.93%-3.78M
-4.52%888K
-52.37%633K
3,984.62%505K
72.72%-1.77M
-312.86%-4.01M
-Change in payables and accrued expense
49.15%4.55M
-195.80%-388K
44.30%-2.69M
-61.74%2M
135.38%3.37M
25.34%3.05M
-76.87%405K
-1,103.99%-4.83M
776.39%5.22M
135.26%1.43M
-Change in other current assets
38.52%-233K
-892.22%-713K
0.72%-1.65M
----
----
---379K
--90K
---1.66M
----
----
-Change in other current liabilities
9.42%-1.49M
16.15%-1.4M
-12.58%-1.59M
-17.43%-6M
-1.44%-1.27M
-25.08%-1.65M
---1.67M
---1.42M
---5.11M
---1.25M
Cash from discontinued investing activities
Operating cash flow
33.50%16.16M
21.54%7.31M
65.91%1.53M
81.08%25.63M
-12.43%6.59M
54.37%12.11M
108.24%6.02M
122.55%924K
4,551.57%14.16M
229.40%7.52M
Investing cash flow
Cash flow from continuing investing activities
-6.44%-2.78M
-157.14%-5.71M
-7.76%-2.75M
-21.94%-9.67M
-31.44%-2.3M
-182.75%-2.61M
-6.07%-2.22M
19.58%-2.55M
1.04%-7.93M
-6.40%-1.75M
Capital expenditure reported
-1.33%-1.67M
-19.96%-1.7M
-99.15%-2.11M
-32.24%-5.22M
---1.09M
---1.65M
---1.42M
---1.06M
-105.74%-3.95M
----
Net PPE purchase and sale
-15.24%-1.1M
-25.47%-1.01M
57.35%-635K
-11.74%-4.45M
-154.77%-1.21M
-3.90%-958K
61.71%-801K
53.04%-1.49M
34.63%-3.99M
694.22%2.2M
Net other investing changes
--0
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-6.44%-2.78M
-157.14%-5.71M
-7.76%-2.75M
-21.94%-9.67M
-31.44%-2.3M
-182.75%-2.61M
-6.07%-2.22M
19.58%-2.55M
1.04%-7.93M
-6.40%-1.75M
Financing cash flow
Cash flow from continuing financing activities
99.74%-14K
99.95%-16K
78.39%-1.37M
-441.31%-43.08M
91.78%-579K
-26,445.00%-5.31M
-33,423.91%-30.84M
-689.19%-6.35M
-113.52%-7.96M
-111.11%-7.04M
Net issuance payments of debt
----
----
----
--0
----
----
----
----
--0
----
Net common stock issuance
--0
----
----
--17.32M
--0
--7.63M
----
----
--0
--0
Cash dividends paid
----
----
----
--0
----
----
----
----
--0
----
Net other financing activities
99.89%-14K
99.96%-16K
78.39%-1.37M
-658.95%-60.41M
91.78%-579K
-64,595.00%-12.94M
-43,958.70%-40.53M
-689.19%-6.35M
24.68%-7.96M
---7.04M
Cash from discontinued financing activities
Financing cash flow
99.74%-14K
99.95%-16K
78.39%-1.37M
-441.31%-43.08M
91.78%-579K
-26,445.00%-5.31M
-33,423.91%-30.84M
-689.19%-6.35M
-113.52%-7.96M
-111.11%-7.04M
Net cash flow
Beginning cash position
24.04%34.45M
-39.75%32.89M
-43.07%35.6M
-2.83%62.55M
-50.19%31.65M
-50.90%27.77M
-2.86%54.6M
-2.83%62.55M
361.80%64.37M
653.59%63.54M
Current changes in cash
219.16%13.37M
105.89%1.59M
67.56%-2.59M
-1,464.01%-27.12M
392.98%3.71M
-39.28%4.19M
-3,930.45%-27.04M
1.16%-7.98M
-103.43%-1.73M
-102.27%-1.27M
Effect of exchange rate changes
255.02%479K
-118.06%-39K
-481.25%-122K
308.14%179K
-10.78%240K
-467.86%-309K
161.19%216K
137.21%32K
4.44%-86K
6,625.00%269K
End cash Position
52.59%48.3M
24.04%34.45M
-39.75%32.89M
-43.07%35.6M
-43.07%35.6M
-50.19%31.65M
-50.90%27.77M
-2.86%54.6M
-2.83%62.55M
-2.83%62.55M
Free cash flow
40.93%13.39M
21.30%4.61M
25.28%-1.22M
156.43%15.96M
-25.70%4.29M
37.27%9.5M
376.07%3.8M
77.63%-1.63M
174.71%6.23M
177.49%5.78M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 33.50%16.16M21.54%7.31M65.91%1.53M81.08%25.63M-12.43%6.59M54.37%12.11M108.24%6.02M122.55%924K4,551.57%14.16M229.40%7.52M
Net income from continuing operations -26.46%1.96M155.21%2.55M-116.21%-761K169.77%9.25M14.21%900K2.42%2.66M124.19%998K137.48%4.69M95.30%-13.26M100.27%788K
Operating gains losses --------------78K--0--------------------
Depreciation and amortization 17.37%2.96M37.99%2.87M43.15%2.67M57.42%9.99M107.99%3.52M48.44%2.52M28.92%2.08M39.40%1.87M59.60%6.34M28.42%1.69M
Other non cash items -9.22%1.81M22.02%2.1M17.53%1.82M29.70%6.97M11.40%1.71M55.98%2M-32.85%1.72M25,766.67%1.55M2,322.07%5.38M--1.54M
Change In working capital 266.49%5.59M-200.13%-4.71M-39.06%-9.06M11.77%-9.44M-243.95%-2.87M48.64%1.53M69.58%-1.57M-13.87%-6.52M27.45%-10.69M84.61%-835K
-Change in receivables 575.38%1.85M-207.60%-3.16M-410.02%-2.72M59.26%-3.68M-204.73%-3.14M61.88%-390K81.99%-1.03M116.53%878K-20.53%-9.03M857.32%3M
-Change in prepaid assets 2.14%907K49.61%947K-181.98%-414K1.02%-1.75M5.93%-3.78M-4.52%888K-52.37%633K3,984.62%505K72.72%-1.77M-312.86%-4.01M
-Change in payables and accrued expense 49.15%4.55M-195.80%-388K44.30%-2.69M-61.74%2M135.38%3.37M25.34%3.05M-76.87%405K-1,103.99%-4.83M776.39%5.22M135.26%1.43M
-Change in other current assets 38.52%-233K-892.22%-713K0.72%-1.65M-----------379K--90K---1.66M--------
-Change in other current liabilities 9.42%-1.49M16.15%-1.4M-12.58%-1.59M-17.43%-6M-1.44%-1.27M-25.08%-1.65M---1.67M---1.42M---5.11M---1.25M
Cash from discontinued investing activities
Operating cash flow 33.50%16.16M21.54%7.31M65.91%1.53M81.08%25.63M-12.43%6.59M54.37%12.11M108.24%6.02M122.55%924K4,551.57%14.16M229.40%7.52M
Investing cash flow
Cash flow from continuing investing activities -6.44%-2.78M-157.14%-5.71M-7.76%-2.75M-21.94%-9.67M-31.44%-2.3M-182.75%-2.61M-6.07%-2.22M19.58%-2.55M1.04%-7.93M-6.40%-1.75M
Capital expenditure reported -1.33%-1.67M-19.96%-1.7M-99.15%-2.11M-32.24%-5.22M---1.09M---1.65M---1.42M---1.06M-105.74%-3.95M----
Net PPE purchase and sale -15.24%-1.1M-25.47%-1.01M57.35%-635K-11.74%-4.45M-154.77%-1.21M-3.90%-958K61.71%-801K53.04%-1.49M34.63%-3.99M694.22%2.2M
Net other investing changes --0------------------------------------
Cash from discontinued investing activities
Investing cash flow -6.44%-2.78M-157.14%-5.71M-7.76%-2.75M-21.94%-9.67M-31.44%-2.3M-182.75%-2.61M-6.07%-2.22M19.58%-2.55M1.04%-7.93M-6.40%-1.75M
Financing cash flow
Cash flow from continuing financing activities 99.74%-14K99.95%-16K78.39%-1.37M-441.31%-43.08M91.78%-579K-26,445.00%-5.31M-33,423.91%-30.84M-689.19%-6.35M-113.52%-7.96M-111.11%-7.04M
Net issuance payments of debt --------------0------------------0----
Net common stock issuance --0----------17.32M--0--7.63M----------0--0
Cash dividends paid --------------0------------------0----
Net other financing activities 99.89%-14K99.96%-16K78.39%-1.37M-658.95%-60.41M91.78%-579K-64,595.00%-12.94M-43,958.70%-40.53M-689.19%-6.35M24.68%-7.96M---7.04M
Cash from discontinued financing activities
Financing cash flow 99.74%-14K99.95%-16K78.39%-1.37M-441.31%-43.08M91.78%-579K-26,445.00%-5.31M-33,423.91%-30.84M-689.19%-6.35M-113.52%-7.96M-111.11%-7.04M
Net cash flow
Beginning cash position 24.04%34.45M-39.75%32.89M-43.07%35.6M-2.83%62.55M-50.19%31.65M-50.90%27.77M-2.86%54.6M-2.83%62.55M361.80%64.37M653.59%63.54M
Current changes in cash 219.16%13.37M105.89%1.59M67.56%-2.59M-1,464.01%-27.12M392.98%3.71M-39.28%4.19M-3,930.45%-27.04M1.16%-7.98M-103.43%-1.73M-102.27%-1.27M
Effect of exchange rate changes 255.02%479K-118.06%-39K-481.25%-122K308.14%179K-10.78%240K-467.86%-309K161.19%216K137.21%32K4.44%-86K6,625.00%269K
End cash Position 52.59%48.3M24.04%34.45M-39.75%32.89M-43.07%35.6M-43.07%35.6M-50.19%31.65M-50.90%27.77M-2.86%54.6M-2.83%62.55M-2.83%62.55M
Free cash flow 40.93%13.39M21.30%4.61M25.28%-1.22M156.43%15.96M-25.70%4.29M37.27%9.5M376.07%3.8M77.63%-1.63M174.71%6.23M177.49%5.78M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.